Literature DB >> 14960425

A systematic review of barriers to delivery of thrombolysis for acute stroke.

Joseph Kwan1, Peter Hand, Peter Sandercock.   

Abstract

BACKGROUND AND
PURPOSE: Barriers within the patient pathway can prevent early administration of thrombolytic therapy in patients admitted with acute stroke. This systematic review aimed to identify such barriers that have been reported in the medical literature.
METHODS: We searched MEDLINE and EMBASE for prospective and retrospective observational studies that assessed the nature of barriers to delivery of thrombolysis for acute stroke.
RESULTS: We identified 54 eligible studies (including a total of 39030 patients). The reported barriers included: (i). the patient or family did not recognise symptoms of stroke or seek urgent help, (ii). the general practitioner (rather than an ambulance) was called first, (iii). the paramedics and emergency department staff triaged stroke as non-urgent, (iv). delays in neuroimaging, (v). inefficient process of in-hospital emergency stroke care, (vi). difficulties in obtaining consent for thrombolysis, and (vii). physicians' uncertainty about administering thrombolysis.
CONCLUSIONS: We identified important pre-hospital and in-hospital barriers that should be overcome if thrombolysis is to be administered to stroke patients efficiently and equitably.

Entities:  

Mesh:

Year:  2004        PMID: 14960425     DOI: 10.1093/ageing/afh064

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  54 in total

1.  Mobile Telestroke During Ambulance Transport Is Feasible in a Rural EMS Setting: The iTREAT Study.

Authors:  Jason M Lippman; Sherita N Chapman Smith; Timothy L McMurry; Zachary G Sutton; Brian S Gunnell; Jack Cote; Debra G Perina; David C Cattell-Gordon; Karen S Rheuban; Nina J Solenski; Bradford B Worrall; Andrew M Southerland
Journal:  Telemed J E Health       Date:  2015-11-24       Impact factor: 3.536

2.  [Concept for allocation of acute stroke patients: evaluation of the quality of diagnosis reached by the emergency medical services of Münster].

Authors:  M Schilling; M Kros; M Ritter; M Ohms; W R Schäbitz; W Kusch; E B Ringelstein; T P Weber; U Harding; A Bohn
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

3.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

4.  Thrombolysis in young adults.

Authors:  Jeffrey C Wagner; Helmi L Lutsep
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

5.  Systemic thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: first Croatian experiences.

Authors:  Vesna Matijević; Domagoj Alvir; Branko Malojčić; Lea Unušić; Svjetlana Supe; Marina Boban; Andrea Bujan-Kovač; Mario Habek; Zdravka Poljaković
Journal:  Neurol Sci       Date:  2010-03-06       Impact factor: 3.307

Review 6.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 7.  How to make better use of thrombolytic therapy in acute ischemic stroke.

Authors:  Geoffrey A Donnan; Stephen M Davis; Mark W Parsons; Henry Ma; Helen M Dewey; David W Howells
Journal:  Nat Rev Neurol       Date:  2011-06-14       Impact factor: 42.937

Review 8.  Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation.

Authors:  Phillip A Scott
Journal:  Emerg Med Clin North Am       Date:  2009-02       Impact factor: 2.264

9.  Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke.

Authors:  N S Rost; S Masrur; M A Pervez; A Viswanathan; L H Schwamm
Journal:  Neurology       Date:  2009-11-25       Impact factor: 9.910

10.  The economics of treating stroke as an acute brain attack.

Authors:  Julien Bogousslavsky; Maurizio Paciaroni
Journal:  BMC Med       Date:  2009-09-23       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.